CompuGroup Medical SE & Co. KGaA Cash Flow Conversion Efficiency
CompuGroup Medical SE & Co. KGaA cash flow conversion efficiency. Based on the latest financial reports, CompuGroup Medical SE & Co. KGaA (COP) has a cash flow conversion efficiency ratio of 0.144x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€93.91 Million ≈ $109.79 Million USD) by net assets (€652.09 Million ≈ $762.36 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of CompuGroup Medical SE & Co. KGaA (2004–2024)
Cash flow conversion efficiency of CompuGroup Medical SE & Co. KGaA from 2004 to 2024. This chart illustrates how CompuGroup Medical SE & Co. KGaA's cash flow conversion efficiency has evolved over time, based on yearly financial data. View CompuGroup Medical SE & Co. KGaA stock price for real-time trading data and today's change.
CompuGroup Medical SE & Co. KGaA Cash Flow Conversion Ratio Explained
CompuGroup Medical SE & Co. KGaA cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
CompuGroup Medical SE & Co. KGaA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of CompuGroup Medical SE & Co. KGaA ranked by their cash flow conversion efficiency. Also see COP stock market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Yantai Tayho Advanced Materials Co Ltd
SHE:002254
|
0.045x |
|
Jiangsu Huahong Technology Co Ltd
SHE:002645
|
-0.010x |
|
Cartrade Tech Limited
NSE:CARTRADE
|
0.008x |
|
Hemab Therapeutics Holdings, Inc. Common Stock
NASDAQ:COAG
|
N/A |
|
Tianrun Crankshaft Co Ltd
SHE:002283
|
0.016x |
|
Barloworld Ltd
JSE:BAW
|
0.282x |
|
Cpi Fim SA
WAR:OPG
|
0.001x |
|
Tennant Company
NYSE:TNC
|
0.009x |
Annual Cash Flow Conversion Efficiency for CompuGroup Medical SE & Co. KGaA (2004–2024)
The table below shows the annual cash flow conversion efficiency of CompuGroup Medical SE & Co. KGaA from 2004 to 2024. Review CompuGroup Medical SE & Co. KGaA (COP) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €648.31 Million ≈ $757.94 Million |
€128.88 Million ≈ $150.68 Million |
0.199x | -25.89% |
| 2023-12-31 | €669.27 Million ≈ $782.45 Million |
€179.53 Million ≈ $209.89 Million |
0.268x | +24.63% |
| 2022-12-31 | €673.82 Million ≈ $787.77 Million |
€145.03 Million ≈ $169.55 Million |
0.215x | -20.26% |
| 2021-12-31 | €612.28 Million ≈ $715.82 Million |
€165.27 Million ≈ $193.22 Million |
0.270x | +15.03% |
| 2020-12-31 | €638.94 Million ≈ $746.98 Million |
€149.93 Million ≈ $175.29 Million |
0.235x | -44.80% |
| 2019-12-31 | €259.92 Million ≈ $303.87 Million |
€110.50 Million ≈ $129.18 Million |
0.425x | -14.88% |
| 2018-12-31 | €273.00 Million ≈ $319.16 Million |
€136.35 Million ≈ $159.41 Million |
0.499x | +37.37% |
| 2017-12-31 | €236.06 Million ≈ $275.98 Million |
€85.82 Million ≈ $100.34 Million |
0.364x | +17.57% |
| 2016-12-31 | €218.65 Million ≈ $255.63 Million |
€67.61 Million ≈ $79.05 Million |
0.309x | -18.69% |
| 2015-12-31 | €192.61 Million ≈ $225.18 Million |
€73.25 Million ≈ $85.63 Million |
0.380x | +109.11% |
| 2014-12-31 | €175.63 Million ≈ $205.33 Million |
€31.94 Million ≈ $37.34 Million |
0.182x | -33.05% |
| 2013-12-31 | €192.64 Million ≈ $225.21 Million |
€52.33 Million ≈ $61.18 Million |
0.272x | -27.15% |
| 2012-12-31 | €179.41 Million ≈ $209.75 Million |
€66.91 Million ≈ $78.22 Million |
0.373x | +34.21% |
| 2011-12-31 | €168.20 Million ≈ $196.65 Million |
€46.74 Million ≈ $54.64 Million |
0.278x | +25.74% |
| 2010-12-31 | €182.73 Million ≈ $213.63 Million |
€40.38 Million ≈ $47.21 Million |
0.221x | -6.68% |
| 2009-12-31 | €185.83 Million ≈ $217.25 Million |
€44.00 Million ≈ $51.45 Million |
0.237x | +67.08% |
| 2008-12-31 | €182.82 Million ≈ $213.74 Million |
€25.91 Million ≈ $30.29 Million |
0.142x | +11.41% |
| 2007-12-31 | €198.02 Million ≈ $231.50 Million |
€25.19 Million ≈ $29.45 Million |
0.127x | -58.08% |
| 2006-12-31 | €54.37 Million ≈ $63.57 Million |
€16.50 Million ≈ $19.29 Million |
0.303x | -43.26% |
| 2005-12-31 | €44.98 Million ≈ $52.59 Million |
€24.06 Million ≈ $28.13 Million |
0.535x | -31.38% |
| 2004-12-31 | €28.87 Million ≈ $33.76 Million |
€22.51 Million ≈ $26.31 Million |
0.779x | -- |
About CompuGroup Medical SE & Co. KGaA
CompuGroup Medical SE & Co. KGaA provides e-health services in Germany, Western and Eastern Europe, North America, and internationally. It operates through Ambulatory Information Systems (AIS), Hospital Information Systems (HIS), and Pharmacy Information Systems (PCS) segments. The Ambulatory Information Systems segment develops and sells management software for registered physicians, medical car… Read more